Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
28.9M
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
26.5M
-
Shares change
-
+761K
-
Total reported value, excl. options
-
$542M
-
Value change
-
+$16.4M
-
Number of buys
-
84
-
Number of sells
-
-88
-
Price
-
$20.42
Significant Holders of CASTLE BIOSCIENCES INC - Common Stock (CSTL) as of Q2 2025
197 filings reported holding CSTL - CASTLE BIOSCIENCES INC - Common Stock as of Q2 2025.
CASTLE BIOSCIENCES INC - Common Stock (CSTL) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26.5M shares
of 28.9M outstanding shares and own 91.81% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (3.15M shares), VANGUARD GROUP INC (2.17M shares), PRINCIPAL FINANCIAL GROUP INC (1.8M shares), Portolan Capital Management, LLC (1.49M shares), DIMENSIONAL FUND ADVISORS LP (1.38M shares), Nuveen, LLC (1.07M shares), WASATCH ADVISORS LP (1.05M shares), CITADEL ADVISORS LLC (889K shares), BRAIDWELL LP (823K shares), and Allianz Asset Management GmbH (714K shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.